Teva’s MS drug and generics to add black box warning for anaphylaxis
The FDA has issued a new boxed warning for Teva Pharmaceuticals’ multiple sclerosis drug Copaxone and generic versions marketed by other companies after some patients …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
